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ABSTRACT 
Altered inhibitory control has been implicated in the development and maintenance of eating 
disorders (ED), however it is unclear how different types of inhibitory control are affected across the 
EDs. We explored whether individuals with bulimia nervosa (BN), binge eating disorder (BED) and 
anorexia nervosa (AN) differed from healthy individuals (HC) on two types of motor inhibitory 
control: proactive inhibition (related to the preparation/initiation of a response) and reactive inhibition 
(withholding a response in reaction to a signal). Ninety-four women (28 AN, 27 BN, 11 BED, 28 HC) 
completed two neuropsychological tasks (a cued reaction time task and a stop signal task), and 
questionnaires assessing clinical variables, mood, anxiety, and inhibitory control. Self-reported 
inhibitory control was poorer in women with BN compared to the HC and AN groups, but greater in 
women with AN compared to all other groups. However, no group differences in reactive inhibition 
were observed. Proactive inhibition was augmented in women with AN compared to HC, and this was 
related to self-reported intolerance of uncertainty. The findings suggest that proactive inhibition may 
be a relevant target for behavioural interventions for AN, and call for further research into the 
relationship between intolerance of uncertainty and proactive inhibition.  
 
 
1. Introduction  
 
Altered inhibitory control, i.e., the ability to appropriately withhold a response (Bartholdy et al., 
2016a; Wardak et al., 2012), has been implicated in the development and maintenance of eating 
disorders (EDs). For example, binge eating (a core symptom in bulimia nervosa [BN] and binge 
eating disorder [BED]) includes a perceived loss of control over eating. Studies report that individuals 
with BN or BED have poorer motor (Galimberti et al., 2012; Wu et al., 2013a) and reward-based 
(Kekic et al., 2016; Manasse et al., 2015) inhibitory control, i.e., the ability to inhibit an inappropriate 
motor response, and the ability to delay gratification, respectively. A meta-analysis revealed that 
individuals with bulimic-type EDs (BN, BED and anorexia nervosa (AN) binge-purge subtype) 
showed a general deficit (of small effect size) in inhibitory control compared to healthy controls (HC) 
using a range of neuropsychological tasks, with a greater deficit to disorder-relevant stimuli observed 
in individuals with BN (Wu et al., 2013b). In contrast, adult women with anorexia nervosa (AN), 
particularly individuals with AN restrictive subtype, have been reported to exhibit excessive reward-
related inhibitory control compared to healthy individuals (Steinglass et al., 2012). However, these 
findings are not always consistent (for reviews, see Bartholdy et al., 2016c; McClelland et al., 2016).  
 
EDs have been modelled along a spectrum of inhibitory control, with AN at the over-controlling end 
and BED at the opposite (impulsive) extremity (Brooks et al., 2012). However, it remains unclear 
whether different types of inhibitory control are similarly affected across the EDs, or whether any 
differences are disorder- or context-specific (Bartholdy et al., 2016c). For example, the evidence for 
such models with respect to reactive motor inhibitory control (i.e., withholding a response in reaction 
to a cue) is inconsistent (Bartholdy et al., 2016c). Moreover, there has been limited exploration of 
proactive motor inhibitory control, i.e., a form of inhibitory control related to the preparation or 
initiation of a response (Meyer & Bucci, 2016). When presented with a stimulus, one must decide 
whether a response is required, and if so, which response is appropriate. Proactive inhibitory control 
may involve adjusting one’s reaction time (e.g., post-error slowing to improve accuracy), or a more 
general withholding of a response (i.e., taking longer to respond) when the need for a response is 
uncertain (see Bartholdy et al., 2016a for further description). As proactive inhibition may relate to 
ambiguity and uncertainty in the requirement for a response, it is possible that the degree to which 
proactive inhibition is exercised is related to one’s tolerance of uncertainty, the degree of evidence 
required for a response to be provided, and one’s priorities regarding performance (e.g., 
speed/accuracy). In the context of EDs, it has been hypothesised that proactive inhibition will 
manifest more strongly in individuals with AN, given the evidence for high perfectionism and 
intolerance of uncertainty in this population (Bartholdy et al., 2016a). However, proactive inhibition 
has not yet been explicitly explored or compared across the EDs. It is of note that the terms 
“impulsivity” and “inhibitory control” are often used to describe opposite patterns of behavioural 
responding, as they will be here for comparability with the existing literature, however these are 
distinct yet related constructs that should not be equated (see Bartholdy et al., 2016c for further 
discussion). 
 
 
These types of motor inhibitory control may be relevant to the way in which symptoms are manifested 
in EDs and how decisions are made across contexts. For example, poor reactive inhibitory control 
may contribute to impulsive behaviours that reflect an inability to resist temptation or overcome 
urges, e.g., binge eating (Svaldi et al., 2014). In contrast, proactive inhibition may be related to 
decision making in the context of uncertainty, e.g., individuals may delay responses until further 
evidence has been gathered (prioritising accuracy over speed of responding), or jump to conclusions 
to reduce the time in which uncertainty is experienced (Bartholdy et al., 2016a). Individuals with EDs 
(particularly AN) are highly intolerant of uncertainty (Sternheim et al., 2011b) and studies have 
revealed intolerance of uncertainty to be positively related to symptom severity (Sternheim et al., 
2011a; Sternheim et al., 2015). On this basis, it is possible that individuals with AN may exercise 
proactive inhibition more strongly in the context of uncertainty compared to HC, and that this may 
underscore their use of more inhibitory, restrictive and/or avoidant behavioural coping strategies.  
 
This study compares proactive and reactive motor inhibitory control in individuals with AN, BN and 
BED to healthy controls (HC) and explores how proactive and reactive inhibition are related to ED 
pathology, anxiety and intolerance of uncertainty. We predict that participants with BN and BED will 
show less motor inhibitory control and participants with AN will show greater inhibitory control 
compared to HC. Poorer inhibitory control will be reflected by faster reaction times (RTs) in the 
context of uncertainty, poorer stop accuracy, and less benefit from warning cues. We also predict that 
poorer inhibitory control will be related to frequency of impulsive ED symptoms, i.e., binge eating 
and purging, and that inhibitory control (particularly proactive inhibition) will be related to 
intolerance of uncertainty. 
 
2. Methods 
 
2.1 Subjects 
Ninety-four adult women participated: 28 with AN, 27 with BN, 11 with BED, and 30 healthy 
normal-weight women (HC). Healthy participants were recruited via online and poster advertisements 
at King’s College London (KCL). Participants with an ED were recruited via online and poster 
advertisements at KCL, via the Eating Disorder Unit at the South London and Maudsley NHS 
Foundation Trust, via online adverts on the Beat website (the UK’s national ED charity), and a 
research recruitment website (www.callforparticipants.com). ED diagnoses were confirmed using the 
Eating Disorder Diagnostic Scale (EDDS; Stice et al., 2000) and the screening module of the 
Structured Clinical Interview for DSM-IV Disorders, Researcher Version (SCID-IV; First et al., 
2002). Participants in the ED groups were required to meet one of the following criteria: (a) DSM-5 
diagnosis of AN and a body mass index (BMI) ≤18.5 kg/m2, (b) DSM-5 diagnosis of BN and a BMI 
>18.5 kg/m
2
, or (c) DSM-5 diagnosis of BED and a BMI >18.5 kg/m
2
. Participants taking 
psychotropic medication were included provided their medication had been stable for ≥14 days prior 
to the study. HC were required to be of healthy BMI (18.5-25 kg/m
2
) and never had an ED or any 
current/previous neurological/psychiatric disorder. Participants were excluded if they were using 
illicit drugs or were pregnant.  
 
2.2 Computer tasks 
 
2.2.1 Cued reaction time (RT) task 
This task was adapted from studies assessing proactive inhibition in individuals with Parkinson’s 
disease (Ballanger et al., 2009; Boulinguez et al., 2009) and healthy individuals (Bartholdy et al., 
2016b). A fixation cross, flanked by two empty boxes, was continuously presented on the screen. On 
each trial, a visual target (large yellow dot) appeared in one of the two boxes. Participants were 
instructed to indicate the location of the target by pressing the corresponding arrow key as quickly as 
possible. On some trials, the target was preceded by a spatially uninformative warning cue (the outline 
of the target appearing in both flanking boxes simultaneously; “cued trials”). This cue was intended to 
reduce uncertainty regarding the requirement of a response, but gave no information regarding what 
motor response would be required: participants were informed that the presence of the cue was 
warning them that the target would soon be appearing, and were reminded to only respond to the 
target and not the cue. The stimulus onset asynchrony (SOA) was manipulated so that the cue-target 
delay varied randomly across four conditions: 0 (no cue), 100, 300 and 500 ms. (See Supplement A 
for a schematic illustration of the task). 
 
 
This study employed a blocked design (three experimental blocks and a practice block). The practice 
block included 18 trials (7 non-cued trials (0 ms SOA), 3 trials at 100 ms SOA, 4 trials at 300 ms 
SOA and 4 trials at 500 ms SOA). One experimental block consisted of only non-cued trials (“pure” 
block) whereas the other two included a mixture of cued and non-cued trials (“mixed” block), 
presented in a pseudorandomised order (the order of cued and non-cued trials was randomised but all 
participants received the same playlist order). The order in which the experimental blocks were 
completed was randomised and counterbalanced across participants. This task assessed proactive 
inhibition in two ways. (1) “Preparation cost” reflects the extent to which one’s responses are slowed 
when not all stimuli are targets for response (Chikazoe et al., 2009). This is calculated by comparing 
the reaction times on all trials in the pure block (i.e., “certain” go trials) to non-cued (0 ms SOA) trials 
in the mixed block (i.e., “uncertain” go trials as the first visual stimulus on each trial may be either a 
target or a warning cue). (2) “Warning benefit” is the degree to which RT on cued trials benefit from 
longer SOAs (i.e., longer time to register the information provided by the warning cue: the next 
stimulus will be a target and therefore a response will certainly be required), calculated by comparing 
RTs on trials at each of the four SOAs (0 ms, 100 ms, 300 ms, 500 ms). These calculations will 
provide a more global assessment of proactive inhibition, indicating the degree to which proactive 
inhibition is more engaged at varying levels of certainty that a response is required. In order to assess 
the relationship between proactive inhibition and clinical variables, an index of preparation cost and 
warning benefit will be calculated by subtracting the mean reaction times in the pure block and the 
500ms SOA trials of the mixed blocks from the non-cued trials of the mixed blocks, respectively.  
 
2.2.2 Stop signal task (SST) 
Participants were asked to provide rapid responses to a stimulus but to withhold their response in the 
presence of a stop signal. On each trial, participants were presented with a blue arrow (target) pointing 
left or right, and were asked to indicate the arrow’s direction as quickly as possible using the 
keyboard’s arrow keys. On a specified number of trials, a stop signal (red dot) was presented at a 
variable delay after the target. Participants were instructed to inhibit their response to the target if the 
stop signal appeared, but to not wait for the stop signal. The stop signal was presented at irregular 
intervals within each block to minimise predictability. The delay between the go signal and stop 
signal is termed the stop signal delay (SSD). The ability to inhibit a response is dependent on the 
length of the SSD: the longer the delay, the harder it is to inhibit a response. The SSD was varied 
from trial to trial in a staircase procedure (in 50 ms increments/decrements, minimum SSD set to 150 
ms) that converged subjects toward an overall performance of 50% for each run. (See Supplement B 
for a schematic illustration of the task). 
 
A blocked design was used, including a practice block (22 trials [of which 7 were stop trials]) and 4 
experimental blocks that varied in the proportion of stop signal trials (0% (60 trials [0 stop trials]), 
15% (200 trials [30 stop trials]), 25% (120 trials [30 stop trials]), 35% (86 trials [30 stop trials]). The 
block comprised of 25% stop trials was used to assess reactive inhibition, consistent with previous 
literature (Verbruggen et al., 2008). Differences in SST outcomes across the blocks were used to 
explore proactive inhibition (difference between the 35% and 15% blocks). The main outcome 
measures included mean RT, mean SSD, mean go accuracy, mean stop accuracy, post-error slowing, 
and stop signal reaction time (SSRT). The SSRT is considered an index of inhibitory control ability 
and is usually calculated by subtracting the SSD that enables convergence at 50% accurate inhibition 
from the mean RT on go trials. However, due to the variability in stop accuracy across the blocks and 
the small number of trials in our design, SSRT was calculated by subtracting the mean SSD on stop 
trials from the nth percentile of the correct go RT distribution, using the formula: SSRT = RT(m)-
SSD, where m = n(number of correct go responses) * probability(responding|signal) (Bartholdy et al., 2016b; 
Nederkoorn et al., 2012). Therefore, if participants correctly stopped on 25% of the trials, the mean 
SSD was subtracted from the 25
th
% RT on correct go trials (0.25*n(correct go trials)) to calculate the SSRT.  
 
2.3 Procedure 
Diagnosis and eligibility was confirmed through a telephone screen, including the EDDS, SCID, and a 
study-specific inclusion and exclusion screening questionnaire developed by us. The EDDS (Stice et 
al., 2000) is a brief validated self-report questionnaire assessing the presence and frequency/severity 
of symptoms within the preceding 3 months. This questionnaire was employed to confirm self-
reported diagnoses in the ED groups, while placing minimal burden on the participants during the 
telephone screening. Eligible participants were invited to attend a single research visit. During this 
visit, participants completed a questionnaire battery including measures assessing clinical 
characteristics (Eating Disorder Examination Questionnaire (EDEQ)), hunger (via 10cm visual 
analogue scales and open questions regarding time since last eaten, expected time of next meal), 
anxiety (Depression, Anxiety and Stress Scale (DASS-21)), Intolerance of Uncertainty Scale (IUS), 
and self-reported impulsivity (Barratt Impulsiveness Scale (BIS-11), Behavioural Inhibition Scale – 
Behavioural Activation Scale (BIS-BAS)). Participants then completed two computer tasks probing 
inhibitory control (cued RT task, SST). Finally, height and weight were measured. Participants were 
debriefed and compensated up to £15 for their time and travel. 
 
2.4 Data analysis 
Data were collected using in-house software and analysed using IBM
®
 SPSS
®
 software (Version 22). 
All tests were two-tailed and the level of significance was set at α=0.05. On the stop signal task, 
SSRT and mean RT (assessing reactive inhibition) were not normally distributed. Difference scores 
(between the blocks with the highest and lowest proportion of stop trials) for stop accuracy and post-
error slowing were normally distributed, but not for go accuracy or mean RT. Logarithmic 
transformations normalised the distribution of the SSRT data, but not the mean RT data. Scores on the 
BIS-11 Attention and Motor subscales and DASS-21 Stress subscale were normally distributed, but 
those for all other subscales were not. Age, ED pathology (EDE-Q global score), binge frequency and 
hunger were not normally distributed.  
 
One-way analyses of variance (ANOVAs) were conducted to assess the effect of group on self-
reported and task-based inhibitory control. Where data were not normally distributed, Kruskal-Wallis 
tests were employed to explore the effect of group, and Friedman’s tests were conducted to explore 
the effects of within-subject variables. Significant main effects were further explored using 
Bonferroni-corrected post-hoc t-tests and Mann-Whitney U tests. For ease of readability, we have 
reported all statistical results from post-hoc tests in a supplementary file (Supplement C). Given the a 
priori predictions of a relationship between inhibitory control and intolerance of uncertainty, a set of 
exploratory post-hoc analyses of covariance (ANCOVAs) were conducted to explore whether the 
main ANOVA results were influenced by confounding effects of intolerance of uncertainty. Group 
differences in specific clinical variables (length of illness, binge frequency and purge frequency) were 
compared across only the ED groups, whereas group comparisons on all other variables (including 
global ED pathology) included all 4 groups. Finally, Pearson and Spearman’s correlations were 
conducted to explore the relationship between inhibitory control during the tasks, with respect to (a) 
task-based measures of proactive and reactive inhibitory control, (b) mood and anxiety (depression, 
anxiety, stress, intolerance of uncertainty); (c) self-reported impulsivity and (d) clinical variables 
(length of illness, global ED pathology (EDEQ global score), BMI, symptom frequency).  
 
2.5 Ethics 
Ethical approval was obtained from the London Bloomsbury NHS Research Ethics Committee (REC 
ref: 15/LO/0251). All participants gave written consent after the procedures were explained and were 
debriefed after the experiment.  
 
3. Results 
 
Ninety-four participants were included in the analysis. Due to computer malfunctions, incomplete 
data were collected from 3 participants (1 HC, 1 AN, 1 BN) on the SST though all completed the 
playlist with 25% stop trial and thus, these participants were excluded from comparisons across 
playlists (to explore proactive inhibition) but were included in assessments of reactive inhibition 
(using the data from the 25% stop trials playlist). A further 4 participants (1 HC, 1 AN, 2 BN) had 
very low levels of stop accuracy across all 4 blocks of the SST, indicating that the task was not 
completed correctly. These participants were excluded from all analyses of SST data. All participants 
completed the proactive inhibition task. Demographic and clinical information for each group is 
reported in Table 1. The groups did not differ in age, but did differ in global ED pathology (EDE-Q 
Global, driven by lower ED pathology in the HC group compared to all other groups) and BMI 
(driven by lower BMI in the AN group compared to all other groups and higher BMI in the BED 
group compared with the HC group). The ED groups differed in illness duration, with the greatest 
duration reported by the AN group and the shortest reported by the BED group. Amongst those who 
endorsed the behaviours, no differences in binge or purge frequency were reported across the ED 
groups. Finally, some individuals in the ED groups reported taking psychotropic medication, mostly 
antidepressants (AN: 39.2%, BN: 18.5%, BED: 9.1%). None of the participants reported taking 
benzodiazepines. One participant in the AN group was taking a low daily dose (75mg) of quetiapine. 
Further information regarding the medication being taken by the present sample is reported in 
Bartholdy et al. (2017). 
 
3.1 Group differences in self-reported anxiety and mood 
Self-reported depression, anxiety, stress and intolerance of uncertainty differed across the groups (all 
p<0.001). This was driven by lower anxiety, stress, depression and intolerance of uncertainty in the 
HC group compared to all ED groups, with no differences on any measure observed between the ED 
groups (Table 2).  
 
3.2 Cued RT task 
Proactive inhibition was assessed using a simple cued RT paradigm. Participants, on average, 
responded fastest when the target followed the presentation of a cue after a 500 ms delay (Table 3). 
RTs were slowest during non-cued trials occurring in blocks containing a mixture of cued and non-
cued trials. 
 
3.2.1 Preparation Cost 
Preparation cost was assessed by comparing mean RTs on all of the trials in the pure block to the non-
cued trials in the mixed blocks (i.e., 0 ms SOA trials). A mixed-effects ANOVA assessing the effects 
of group and condition revealed a main effect of condition (F(1, 90)=177.627, p<0.001), whereby 
participants responded significantly faster on non-cued trials in the pure block compared to the mixed 
block (Table 3). No main effect of group (F(3,90)=0.792, p=0.501) or interaction between group and 
condition (F(3, 90)=1.535, p=0.211) was observed. 
 3.2.2 Warning benefit 
A mixed-effects ANOVA was conducted to assess the effects of and interaction between SOA (0 ms, 
100 ms, 300 ms, 500 ms) and group on proactive inhibition. This revealed a significant effect of SOA
1
 
(F(2.431, 218.776)=162.919, p<0.001), but no significant effect of group (F(3, 90)=1.823, p=0.149) 
nor group by SOA interaction (F(7.293, 218.776)=1.074, p=0.382). Post-hoc t-tests revealed 
significant differences between all SOAs, with fastest RTs observed at 500 ms SOAs, and slowest at 0 
ms SOA (i.e., non-cued trials).  
 
3.2.3  Effects of anxiety and intolerance of uncertainty on proactive inhibition 
The main effect of SOA on RT was unaffected after inclusion of covariates for both preparation cost 
and warning benefit, however, a main effect of group on warning benefit emerged after covarying for 
intolerance of uncertainty (IUS Total: F(3, 89)=3.130, p=0.030; IUS Self-Implications subscale: F(3, 
89)=2.911, p=0.039). Post-hoc t-tests comparing RTs between groups (in the absence of covariates) 
revealed these group differences to be predominantly due to greater RTs in the AN group compared to 
HCs at all SOAs in the mixed block but not the pure block, though these findings did not survive 
correction for multiple comparisons. This suggest that group differences in proactive inhibition exist 
between AN and HC, but are masked by individual differences in intolerance of uncertainty. 
 
Uncorrected exploratory correlational analyses exploring the relationship between proactive inhibition 
outcomes on the cued RT task and intolerance of uncertainty (IUS Total and subscale scores) across 
all of the groups revealed a positive association between intolerance of uncertainty and preparation 
cost (IUS Self-Implications subscale: r
s
=.217, p=0.036), but no other relationships were observed (all 
r
s≥.156, p≥0.134). However, these findings did not survive Bonferroni correction for multiple 
comparisons.  
 
3.3 Stop signal task 
 
3.3.1 Strategic proactive inhibition assessed by manipulating uncertainty across task 
blocks 
 
3.3.1.1 Effect of stop probability 
 
Group differences in strategic proactive inhibition were assessed using a block-wise manipulation, 
comparing performance across four blocks of the task that varied in the proportion of stop trials (0%, 
15%, 25%, 35%).  
 
Mean RT on go trials (χ2(3)=97.690, p<0.001) and stop accuracy (F(2,166)=22.672, p<0.001) 
increased with the degree of stop signal probability, whereas go accuracy decreased (trend: 
χ2(3)=6.957, p=0.073). Participants reacted more quickly and with greater go accuracy during the 
block with no stop trials compared to blocks during which stop trials occurred, and showed the 
greatest RTs and stop accuracy during the block with the greatest stop trials. Post-error slowing also 
increased as stop signal probability increased, though this was not significant (F(2,166)=0.653, 
p=0.522).  
 
3.3.1.2 Main effects of group and group-by-block interactions 
 
The AN group consistently showed the slowest RTs on go trials and the greatest stop accuracy, 
whereas the BED group showed the fastest RTs (see Supplement D for a visual illustration).  
 
As the distribution of mean RT and go accuracy data could not be normalised, Kruskal-Wallis tests 
were conducted to explore the main effect of group separately for each block. These did not find any 
                                                     
1
 Due to violation of the assumption of sphericity, Huynh Feldt degrees of freedom and p values are 
reported. 
significant effect of group on mean RT on any of the blocks (0% stop trials: χ2(3)=4.440, p=0.218; 
15% stop trials: χ2(3)=2.511, p=0.473; 25% stop trials: χ2(3)=3.152, p=0.369; 35% stop trials: 
χ2(3)=5.049, p=0.168) or on go accuracy on any of the blocks (0% stop trials: χ2(3)=5.459, p=0.141; 
15% stop trials: χ2(3)=2.980, p=0.395; 25% stop trials: χ2(3)=2.707, p=0.439; 35% stop trials: 
χ2(3)=2.972, p=0.396).  
 
Mixed-design ANOVAs similarly revealed no effect of group on stop accuracy (F(3,83)=1.312, 
p=0.276) or post-error slowing (F(3,83)=0.893, p=0.449), or interactions between group and block on 
either measure (stop accuracy: F(6,166)=1.028, p=0.409; post-error slowing: F(6,166)=0.726, 
p=0.629).  
 
3.3.1.3 Controlling for confounding effects of intolerance of uncertainty on proactive 
inhibition 
 
The main effect of block on stop accuracy reached trend-level significance after controlling for 
intolerance of uncertainty (IUS Total: F(2,164)=3.016, p=0.052; IUS Self-Implications subscale 
scores: F(2, 164)=2.886, p=0.059), suggesting that intolerance of uncertainty contributed substantially 
to the variability of stop accuracy across participants, reducing the sensitivity of our initial analysis.  
 
Post-hoc exploratory correlational analysis did not reveal any relationships between proactive 
inhibition outcomes on the SST and intolerance of uncertainty (all r
s
>-.154, p≥0.155). 
 
3.3.2 Reactive inhibition 
Reactive inhibition was assessed from mean RT on go trials and the SSRT (mean SSD subtracted 
from the go RT that corresponded to the participant’s inhibition accuracy). As many participants did 
not converge at 50% inhibition accuracy as intended by the task, the mean SSD and inhibition (stop) 
accuracy (%) were analysed as secondary outcome measures to aid interpretation.  
 
Group differences in reactive inhibition were assessed using a single block on the SST that included 
75% go trials and 25% stop trials. The groups did not differ statistically in any of the outcome 
measures (SSRT: F(3,89)=1.609, p=0.193; stop accuracy: F(3,89)=1.355, p=0.262; mean RT: 
χ2(3)=3.152, p=0.369; mean SSD: χ2(3)=4.820, p=0.185). However, visual inspection of the group 
differences did suggest that the (non-significant) differences were in the direction we had predicted, 
i.e., the AN group showed the greatest stop accuracies, mean stop signal delays and mean RTs 
(suggesting a more inhibited approach), whereas the BN group showed the poorest accuracies, 
smallest stop signal delays and fastest RTs (Table 4). Surprisingly though, the AN group showed the 
largest SSRT (thought to index greater impulsivity/poorer inhibitory control), whereas the BN group 
showed the smallest SSRTs.  
 
3.3.2.1 Controlling for confounding effects of anxiety and intolerance of uncertainty on 
proactive inhibition 
 
Including self-reported intolerance of uncertainty (total/subscale scores) as a covariate did not affect 
the initial observations: no group differences were observed on measures of reactive inhibition (stop 
accuracy (%), log-transformed SSRT). 
 
3.4 Questionnaire outcomes 
Self-reported impulsivity was explored using the BIS-11 and the behavioural inhibition subscale 
(BIS) of the BIS-BAS questionnaire.  
 
As some of the subscales of the BIS-11 and the BIS subscale were non-normally distributed, Kruskal-
Wallis analyses were conducted to explore differences between group means. These revealed a 
significant difference between groups on the BIS subscale of the BIS-BAS, the BIS-11 Attention and 
Motor subscale scores and BIS-11 total scores, whereas no group differences were observed on the 
BIS-11 Non-planning subscale (Table 5). Post-hoc Mann-Whitney U tests revealed that while the AN 
and BN groups reported greater impulsivity in some domains compared to HC (BIS-11 Attention 
(both AN and BN), BIS (AN only) and BIS-11 Total (BN only)), the BN group reported greater 
overall impulsivity compared to the AN group (BIS-11 Total) and the AN group reported less motor 
impulsivity (BIS-11 Motor) compared to all other groups. No other comparisons remained significant 
after correction for multiple comparisons.  
 
3.5 Correlations between task-based and clinical variables 
 
 
Reactive inhibition outcomes showed negative associations with BMI (SSRT, mean RT [trend]) and 
binge frequency (SSRT [trend]), but no other relationships were observed (Table 6). This indicates 
that individuals with lower BMIs showed longer RTs on go trials. In contrast to what was predicted, 
lower BMI and reduced frequency of binge eating episodes were associated with greater SSRTs.  
 
Proactive inhibition outcomes also showed a relationship with clinical variables across the ED groups, 
with go accuracy change negatively associated with length of illness and change in post-error slowing 
negatively associated with purge frequency. This suggests that individuals reporting a longer illness 
duration and more frequent purging episodes show less adjustment of their motor responses as 
uncertainty changes, suggesting poorer proactive inhibition. However, none of these findings survived 
correction for multiple comparisons, therefore the findings must be interpreted with caution. 
 
 
4. Discussion 
 
This study investigated whether proactive and reactive motor inhibitory control differed across ED. 
The self-report data indicated that individuals with BN considered themselves to have less overall 
inhibitory control compared to those with AN and HCs, whereas individuals with AN reported the 
greatest motor inhibitory control compared to all other groups (see Section 3.4). In terms of 
behavioural performance on the tasks, the data did not reveal any group differences in reactive 
inhibitory control were observed, but individuals with AN showed greater proactive inhibition 
compared to HC, and this appears to be related to individual differences in intolerance of uncertainty. 
Therefore specific elements of inhibitory control appear to be different in different ED. Overall, the 
data provide limited support for a spectrum model of EDs based on motor inhibitory control, 
particularly with regards to perceived (self-reported) inhibitory control, but suggest that the different 
subtypes of motor inhibitory control (proactive/reactive) may be differentially implicated within each 
of the EDs. 
 
We did not observe any differences in reactive inhibitory control between the groups. This is in 
contrast to the literature supporting impaired reactive inhibitory control in individuals with binge-type 
eating disorders (for reviews, see Bartholdy et al., 2016c; Wu et al., 2013b), however such findings 
have not been consistently reported in the literature (Boisseau et al., 2012; Claes et al., 2006). These 
findings suggest that reactive motor inhibitory control to stimuli that is not disorder-specific may not 
be impaired in binge-type EDs, and therefore seems unlikely to be a general motor deficit contributing 
to ED psychopathology. In contrast to that hypothesised in spectrum models of EDs (Brooks, 2016; 
Brooks et al., 2012), the AN group showed the largest SSRTs (thought to reflect poorer reactive 
inhibitory control), although was not significantly different from the other groups, and poorer 
inhibitory control on the SST in AN has been reported previously (Galimberti et al., 2012). The 
discrepancy between our findings and those reported by previous studies may be due to the task and 
computational methods used. Typically, versions of the SST that make use of the tracking method (as 
in the present study) dynamically adjust the SSD to enable 50% inhibition accuracy: in this context, 
the SSRT can be calculated by subtracting the mean SSD from the mean RT on correct go trials 
(Logan, 1994; Verbruggen et al., 2008). However, if convergence at 50% inhibition accuracy is not 
achieved, this conventional method of SSRT calculation is not suitable (for review, see Verbruggen & 
Logan, 2008). In the present study, convergence at ~50% correct inhibition for all blocks was only 
achieved by a small proportion of each group, which may have been due to either the small number of 
trials per block, or the manipulation of the probability of a stop trial occurring. We therefore used an 
alternative method for calculating the SSRT, which has been used previously (Bartholdy et al., 2016b; 
Nederkoorn et al., 2012). Unfortunately, our findings question the sensitivity of this alternative 
method of SSRT calculation as an index of impulsivity: as in the present study, SSRTs appeared to be 
largely driven by the relatively longer mean RTs and greater stop accuracy in the AN group. In other 
words, if the go RT used to calculate the SSRT is determined by the stop accuracy, then in the context 
of similar RTs, a greater stop accuracy will result in greater SSRTs. Similarly, in the context of 
similar stop accuracies, greater RTs will result in greater SSRTs. However, greater RT and greater 
stop accuracies can be argued to reflect greater inhibitory control, so do not reflect what would 
typically be considered as impulsive behaviour. Thus, for cases whereby convergence at 50% stop 
accuracy has not been reached, it may be more beneficial to consider all behavioural outcomes 
together and interpret performance on one measure in the context of other behavioural indices, rather 
than relying on one outcome measure.  
 
Our findings are consistent with the proposal that proactive inhibition is involved in ED pathology 
(Bartholdy et al., 2016a). Inspection of the outcome measures of two discrete computer tasks 
assessing proactive inhibition suggests the AN group tend to favour a more cautious approach in their 
responding compared to the other groups, i.e., showing slower mean RTs in every condition of both 
tasks and the greatest stop accuracy on the SST. This suggests individuals with AN prioritise accuracy 
over speed and may reflect greater tonic proactive inhibition. This is in accord with reports that 
individuals with AN show more perfectionistic behaviours (e.g., longer times checking their work; 
Lloyd et al., 2014) and attribute increased importance to decision accuracy (Sternheim et al., 2011b). 
Moreover, after controlling for individual differences in intolerance of uncertainty, we found that 
proactive inhibition (on the cued RT task) differed between the groups: this was driven by differences 
in the effect of warning cues on the cued RT task between the AN and HC groups. The AN group 
showed a greater preparation cost (i.e., greater slowing of responses during non-cued trials in the 
mixed block compared to the pure block) as they demonstrated longer RTs at all SOAs during the 
mixed block compared to the HC group, but no differences in RT in the pure block. This suggests 
that, relative to HCs, the AN group engage in greater proactive slowing in the context of uncertainty. 
Arguably, these findings may simply reflect generally slower behavioural responding, though there is 
little evidence to suggest that AN is associated with a general slowing of motor responses on such 
tasks (see Bartholdy et al., 2016c for review). It can be speculated that exaggerated proactive 
inhibition may contribute to the inhibited temperament thought to be characteristic of AN: i.e., 
contexts of uncertainty or symptom provocation (i.e., in the presence of food) may increase proactive 
inhibition, which may promote more inhibited, avoidant and/or restrictive behaviours as a means of 
dealing with the anxiety-provoking situation, and may impede the potential efficacy of exposure 
treatments for AN (Koskina et al., 2013).  
 
Based on the evidence implying the involvement of altered inhibitory control in EDs, behavioural 
interventions have emerged that aim to manipulate inhibitory control as a means of improving ED 
symptoms (for reviews, see Bartholdy et al., 2016c; Stice et al., 2016; Turton et al., 2016). The 
present findings suggest that proactive inhibition may be a relevant target for behavioural 
interventions for AN, and future studies should explore whether interventions that reduce anxiety 
related to uncertainty have any ancillary benefits on proactive inhibition. In contrast, the lack of any 
group differences in reactive inhibition suggests that behavioural paradigms may not wish to focus on 
reactive inhibition in a general context, though future studies may wish to further explore the degree 
to which disorder-relevant stimuli affects reactive inhibition specifically to determine its utility as a 
target of manipulation in such behavioural interventions. 
 
This study has some limitations. The sample size of the BED group was small, and thus may not be a 
representative sample of the BED population. Moreover, this group has a comparably low average 
BMI (but high standard deviation) for this disorder, possibly due to the relatively short illness 
duration. This may have contributed to the lack of statistically significant results in the behavioural 
tasks, as a trend towards a positive relationship between BMI and SSRT has previously been reported 
in obese participants with and without BED (Mole et al., 2015), and differences in SSRT across 
different weight categories have been reported (see Bartholdy et al., 2016c for review). However, 
such a relationship was not observed in the present study (when all groups were considered together), 
thus the influence of BMI, if any, may be small. Moreover, while some studies have found evidence 
of poor motor inhibitory control in BED (Mole et al., 2015; Svaldi et al., 2014) this is not always the 
case (Wu et al., 2013a). In addition to limitations regarding sample size, there are limits with regards 
to generalisability of the findings as all the participants were women. This was specified in our 
inclusion criteria to reflect the relatively greater prevalence of EDs in women. However, a meta-
analysis of healthy adults did not observe any sex differences in tasks involving inhibitory control, 
such as the SST (Cross et al., 2011), though sex differences in proactive inhibition have not yet been 
explored.  
 
This study is the first to explicitly explore proactive inhibition in EDs using multiple neurocognitive 
methods for assessing proactive inhibition, and provides early empirical support for altered proactive 
inhibition as a correlate of AN. Our findings suggest that motor inhibitory control is not uniformly 
implicated across EDs. Studies of proactive inhibition in larger samples (particularly in the BED 
group) are required to provide more definitive evidence on the involvement of proactive and reactive 
inhibition in EDs. 
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Table 1. Demographic and clinical information 
  HC (n=28) AN (n=28) BN (n=27) BED (n=11) 
Statistical 
evaluation of 
group 
differences
a
 
Demographic information 
(mean [SD]) 
     
 Age (years) 24.64 (5.14) 30.00 (10.51) 25.30 (6.85) 28.73 (11.33) 
χ
2
(3)=4.590, 
p=0.204 
 BMI (kg/m
2
) 22.04 (2.03) 16.55 (1.79) 22.57 (3.30) 28.86 (6.92) 
F(3, 90)=37.081, 
p<0.001 
 Right handed (%) 82.14% 78.57% 96.30% 81.81%  
 
% completed 
undergraduate degree 
100.00% 77.78% 79.17% 88.89%  
ED-related variables (mean 
[SD]) 
     
 EDE-Q Global 0.53 (0.66) 3.80 (1.29) 4.29 (1.00) 3.65 (1.08) 
χ
2
(3)=57.166, 
p<0.001 
 
Self-reported length of 
illness (years) 
- 10.59 (10.04) 5 (5.51) 2.32 (3.99) 
χ
2
(2)=14.163, 
p=0.001 
 
Lowest weight at current 
height (kg) 
- 35.81 (9.31) 49.78 (7.08) 62.55 (15.83)  
 
Binge eating episodes (n 
reported in preceding 28 
days [mean frequency 
[SD])
b
 
0 
(0.00 [0.000]) 
8 
(11.14 [22.34]) 
27 
(18.04 [22.78]) 
11 
(8.00 [5.15]) 
χ
2
(2)=2.466, 
p=0.291 
 
Purge frequency
c
 (n 
reported in preceding 28 
0 
(0.00 [0.000]) 
12 
(35.93 [83.97]) 
25 
(24.65 [24.60]) 
0 
(0.00 [0.000]) 
t(11.494)=1.724, 
p=0.111 
days [mean frequency 
[SD]) 
 
Self-induced vomiting 
episodes (n reported in 
preceding 28 days [mean 
frequency [SD]) 
0 
(0.00 [0.000]) 
9 
(28.19 [82.78]) 
19 
(16.94 [20.48]) 
0 
(0.00 [0.00]) 
 
 
Laxative use (n reported 
in preceding 28 days 
[mean frequency [SD]) 
0 
(0.00 [0.000]) 
5 
(9.07 [28.20]) 
12 
(6.00 [9.90]) 
0 
(0.00 [0.00]) 
 
 
Diuretic use (n reported 
in preceding 28 days 
[mean frequency [SD]) 
0 
(0.00 [0.000]) 
0 
(0.00 [0.00]) 
4 
(1.70 [5.60]) 
0 
(0.00 [0.00]) 
 
 
n reporting comorbid 
diagnoses (%) 
0 (0%) 15 (53.2%) 9 (33.3%) 2 (18.2%)  
 
n currently taking 
medication
d
 (%, n taking 
antidepressants) 
0 (0%) 19 (67.9%, 11) 8 (29.6%, 5) 5 (45.5%, 1)  
Hunger (mean [SD])      
 VAS scale 0.31 (0.25) 0.20 (0.23) 0.28 (0.28) 0.40 (0.31) 
χ
2
(3)=6.065, 
p=0.109 
 
a
Group differences were evaluated using Kruskal-Wallis chi-square tests, one-way ANOVAs and t-
tests as appropriate 
b
Comparison between those who reported binge eating in the AN, BN and BED groups. 
c
Comparison between those who reported any purging behaviour (including self-induced vomiting, 
laxative use or diuretic use) in the AN and BN groups. 
d
Not including oral or internal contraceptive medication 
 
Table 2. Means (SDs) and comparisons between groups for self-reported depression, anxiety, stress 
and intolerance of uncertainty. 
 Means (SD) Kruskal
-Wallis 
Post-hoc Mann-Whitney U tests 
 HC AN BN BED  HC vs. 
AN 
HC vs. 
BN 
HC 
vs. 
BED 
AN vs. 
BN 
AN vs. 
BED 
BN vs. 
BED 
DASS-
21 Total 
5.96 
(5.68
7) 
28.33 
(15.3
50) 
29.64 
(15.2
50) 
26.82 
(16.5
82) 
χ2(3)=40
.605, 
p<0.001 
U=73.
50, z=-
5.042, 
p<0.00
1* 
U=37.
50, z=-
5.504, 
p<0.00
1* 
U=19.
00, 
z=-
4.181, 
p<0.0
01* 
U=315
.50, 
z=-
0.404, 
p=0.68
7 
U=140
.00, 
z=-
0.274, 
p=0.78
4 
U=119
.00, 
z=-
0.636, 
p=0.52
5 
DASS-
21 
Depress
ion 
2.44 
(4.44
9) 
20.81 
(13.5
79) 
18.40 
(12.2
88) 
18.91 
(11.8
11) 
χ2(3)=38
.359, 
p<0.001 
U=76.
00, z=-
5.066, 
p<0.00
1* 
U=64.
00, z=-
5.079, 
p<0.00
1* 
U=12.
50, 
z=-
4.488, 
p<0.0
01* 
U=296
.50, 
z=-
0.753, 
p=0.45
2 
U=136
.50, 
z=-
0.387, 
p=0.69
9 
U=136
.00, 
z=-
0.052, 
p=0.95
9 
DASS-
21 
Anxiety 
2.81 
(3.81
3) 
13.04 
(11.0
71) 
16.88 
(10.8
18) 
13.82 
(10.9
71) 
χ2(3)=31
.976, 
p<0.001 
U=136
.00, 
z=-
4.028, 
p<0.00
1* 
U=61.
50, z=-
5.113, 
p<0.00
1* 
U=33.
00, 
z=-
3.810, 
p<0.0
01* 
U=262
.00, 
z=-
1.386, 
p=0.16
6 
U=137
.50, 
z=-
0.355, 
p=0.72
3 
U=114
.00, 
z=-
0.810, 
p=0.41
8 
DASS-
21 
Stress 
6.67 
(5.34
9) 
22.81 
(10.6
74) 
24.00 
(10.8
17) 
20.91 
(11.6
74) 
χ2(3)=35
.553, 
p<0.001 
U=82.
50, z=-
4.894, 
p<0.00
1* 
U=58.
50, z=-
5.129, 
p<0.00
1* 
U=39.
00, 
z=-
3.553, 
p<0.0
01* 
U=312
.00, 
z=-
0.468, 
p=0.64
0 
U=131
.50, 
z=-
0.549, 
p=0.58
3 
U=113
.00, 
z=-
0.843, 
p=0.39
9 
IUS 
Total 
43.78 
(14.8
25) 
81.52 
(30.1
95) 
79.54 
(27.9
04) 
76.82 
(21.2
31) 
χ2(3)=32
.238, 
p<0.001 
U=88.
50, z=-
4.777, 
p<0.00
1* 
U=92.
00, z=-
4.498, 
p<0.00
1* 
U=27.
00, 
z=-
3.914, 
p<0.0
01* 
U=318
.50, 
z=-
0.348, 
p=0.72
8 
U=127
.00, 
z=-
0.692, 
p=0.48
9 
U=128
.50, 
z=-
0.309, 
p=0.75
7 
IUS 
Self-
Implica
tions 
19.74 
(5.86
8) 
37.26 
(14.7
30) 
37.50 
(13.2
15) 
34.55 
(11.7
50) 
χ2(3)=31
.020, 
p<0.001 
U=92.
50, z=-
4.710, 
p<0.00
1* 
U=92.
50, z=-
4.495, 
p<0.00
1* 
U=35.
50, 
z=-
3.645, 
p<0.0
01* 
U=335
.50, 
z=-
0.037, 
p=0.97
1 
U=122
.00, 
z=-
0.854, 
p=0.39
3 
U=126
.00, 
z=-
0.395, 
p=0.69
3 
IUS 
Unfair 
Spoils 
22.11 
(6.60
0) 
38.70 
(14.1
47) 
36.56 
(13.0
42) 
37.82 
(10.0
78) 
χ2(3)=28
.797, 
p<0.001 
U=101
.50, 
z=-
4.554, 
p<0.00
1* 
U=118
.00, 
z=-
4.025, 
p<0.00
1* 
U=29.
00, 
z=-
3.852, 
p<0.0
01* 
U=288
.00, 
z=-
0.907, 
p=0.36
4 
U=124
.50, 
z=-
0.774, 
p=0.43
9 
U=131
.00, 
z=-
0.224, 
p=0.82
3 
*p<0.05 after Bonferroni correction. Uncorrected p-values are presented in the table. 
 
Table 3. Mean (SD) reaction time and accuracy in the pure (non-cued trials only) and mixed (mixture 
of cued and non-cued trials) blocks of the simple cued reaction time paradigm. 
   SOA HC AN BN BED 
Reaction time (ms)          
  Pure 
348.98 
(55.10) 
365.65 
(70.75) 
367.97 
(72.58) 
339.91 
(45.83) 
  0 ms 
393.22 
(51.24) 
426.18 
(85.42) 
411.04 
(52.12) 
408.15 
(55.44) 
  100 ms 
363.08 
(48.61) 
399.74 
(76.36) 
372.23 
(46.07) 
365.67 
(43.81) 
  300 ms 
375.41 
(48.38) 
420.30 
(82.94) 
385.75 
(47.66) 
376.47 
(56.49) 
  500 ms 
324.37 
(47.98) 
363.79 
(82.21) 
338.55 
(58.56) 
331.42 
(38.62) 
Accuracy (%)           
  Pure 98.8% (1.4%) 99.1% (1.6%) 97.8% (6.8%) 98.2% (2.5%) 
  0 ms 99.6% (1.1%) 98.1% (5.6%) 99.6% (1.1%) 99.5% (1.0%) 
  100 ms 97.7% (2.9%) 98.2% (2.8%) 96.3% (4.1%) 98.6% (2.3%) 
  300 ms 97.7% (5.2%) 98.4% (2.7%) 98.0% (3.5%) 98.6% (2.3%) 
  500 ms 96.6% (5.1%) 99.3% (1.8%) 98.0% (4.0%) 97.3% (5.2%) 
 
 
Table 4. Means (SD) for each stop signal task (SST) outcome measure in each group. 
 HC AN BN BED 
SSRT 
558.15 
(297.551) 
628.89 
(322.635) 
512.88 
(255.743) 
517.64 
(289.703) 
Mean RT (ms) 
549.84 
(228.227) 
614.60 
(261.978) 
525.00 
(210.829) 
531.55 
(256.044) 
Mean SSD 
272.72 
(186.502) 
300.42 
(192.440) 
245.83 
(156.607) 
264.57 
(196.490) 
Stop Accuracy 
(%) 
48.1% (15.1%) 50.7% (14.9%) 43.3% (16.2%) 42.7% (14.2%) 
 
 Table 5. Mean (SD) scores on self-reported measures of behavioural inhibitory control and statistical 
comparisons between groups. 
 Means (SD) Kruska
l-Wallis 
Post-hoc Mann-Whitney U tests 
 HC AN BN BED  HC 
vs. 
AN 
HC 
vs. 
BN 
HC 
vs. 
BED 
AN 
vs. 
BN 
AN 
vs. 
BED 
BN 
vs. 
BED 
BIS-
11 
Total 
60.2
6 
(10.2
42) 
61.8
5 
(9.8
71) 
69.1
8 
(11.7
02) 
67.9
1 
(13.4
87) 
χ2(3)=9.
683, 
p=0.021 
U=36
1.00, 
z=-
0.061, 
p=0.9
52 
U=20
1.50, 
z=-
2.493, 
p=0.0
13 
U=10
0.00, 
z=-
1.562, 
p=0.1
18 
U=19
2.50, 
z=-
2.658, 
p=0.0
08* 
U=10
3.00, 
z=-
1.466, 
p=0.1
43 
U=13
2.50, 
z=-
0.172, 
p=0.8
64 
BIS-
11 
Atten
tion 
14.7
0 
(4.67
2) 
18.8
9 
(3.8
56) 
19.4
0 
(4.38
7) 
19.2
7 
(4.75
6) 
χ2(3)=1
5.079, 
p=0.002 
U=18
1.50, 
z=-
3.175, 
p=0.0
01* 
U=15
7.50, 
z=-
3.307, 
p=0.0
01* 
U=72.
50, 
z=-
2.455, 
p=0.0
14 
U=32
2.50, 
z=-
0.276, 
p=0.7
83 
U=14
3.00, 
z=-
0.178, 
p=0.8
59 
U=13
0.50, 
z=-
0.241, 
p=0.8
09 
BIS-
11 
Moto
r 
22.0
0 
(3.54
1) 
19.0
0 
(4.6
74) 
23.2
6 
(4.77
6) 
25.2
7 
(5.98
5) 
χ2(3)=1
6.141, 
p=0.001 
U=20
5.50, 
z=-
2.764, 
p=0.0
06* 
U=29
2.50, 
z=-
0.828, 
p=0.4
07 
U=97.
00, 
z=-
1.667, 
p=0.0
95 
U=16
3.00, 
z=-
3.211, 
p=0.0
01* 
U=58.
00, 
z=-
2.925, 
p=0.0
03* 
U=10
8.00, 
z=-
1.018, 
p=0.3
09 
BIS-
11 
Non-
plann
ing 
12.0
0 
(2.78
7) 
12.8
9 
(3.7
86) 
13.6
0 
(3.41
6) 
12.7
3 
(4.10
1) 
χ2(3)=3.
473, 
p=0.324 
U=32
2.50, 
z=-
0.732, 
p=0.4
64 
U=23
9.00, 
z=-
1.814, 
p=0.0
70 
U=13
9.00, 
z=-
0.309, 
p=0.7
57 
U=27
9.00, 
z=-
1.079, 
p=0.2
81 
U=13
9.50, 
z=-
0.292, 
p=0.7
70 
U=10
6.00, 
z=-
1.092, 
p=0.2
75 
BIS-
BAS 
BIS 
subsc
ale  
21.7
0 
(3.51
7) 
25.7
8 
(1.6
72) 
24.1
6 
(2.92
5) 
24.4
5 
(3.38
7) 
χ2(3)=1
9.059, 
p<0.001 
U=12
0.50, 
z=-
4.258, 
p<0.0
01* 
U=20
2.00, 
z=-
2.493, 
p=0.0
13 
U=83.
00, 
z=-
2.116, 
p=0.0
34 
U=23
0.50, 
z=-
1.990, 
p=0.0
47 
U=12
5.00, 
z=-
0.770, 
p=0.4
41 
U=12
5.00, 
z=-
0.433, 
p=0.6
65 
*p<0.05 after Bonferroni correction. Uncorrected p-values are presented in the table. 
 
 
Table 6. Spearman’s correlation coefficients describing the relationship between clinical variables and 
task-based measures of inhibitory control across the ED groups. 
 
Proactive inhibition 
 
Reactive 
inhibition 
 
(Simple cued 
RT) 
 (Stop signal task)  
(Stop signal 
task) 
  SSRT 
Mean 
RT 
  
Go 
accura
cy 
change 
Mean 
RT 
change 
Stop 
accura
cy 
change 
Post-
error 
slowin
g 
change 
  
Preparati
on cost 
W
ar
ni
ng 
be
ne
fit 
Length   r
s
=-   r
s
=- r
s
=0.02 r
s
=- r
s
=0.05   r
s
=0.174, r
s
=
of 
illness 
r
s
=0.15
1, 
p=0.22
7  
0.106, 
p=0.39
5 
0.314, 
p=0.01
4 
7, 
p=0.83
9 
0.110, 
p=0.39
9 
2, 
p=0.68
9 
p=0.174 0.
18
6, 
p=
0.
14
5 
EDE-Q 
Global 
 r=-
0.040, 
p=0.74
7  
 
r=0.04
3, 
p=0.73
0 
  
r
s
=-
0.211, 
p=0.10
2 
r
s
=-
0.055, 
p=0.67
3 
r
s
=-
0.146, 
p=0.26
2 
r
s
=0.16
5, 
p=0.20
4 
  
r
s
=-0.014, 
p=0.914 
r
s
=
0.
01
9, 
p=
0.
88
0 
Binge 
frequen
cy 
 r=-
0.041, 
p=0.74
4  
 r=-
0.047, 
p=0.70
6 
  
r
s
=0.05
2, 
p=0.69
0 
r
s
=-
0.065, 
p=0.62
0 
r
s
=-
0.122, 
p=0.34
8 
r
s
=0.01
4, 
p=0.91
4 
  
r
s
=-0.232, 
p=0.067 
r
s
=
-
0.
16
8, 
p=
0.
18
9 
Purge 
frequen
cy 
 r
s
=-
0.055, 
p=0.66
3  
 r
s
=-
0.061, 
p=0.62
9 
  
r
s
=-
0.066, 
p=0.61
4 
r
s
=0.02
5, 
p=0.85
0 
r=0.193
, 
p=0.13
6 
r=-
0.271, 
p=0.03
4 
  
r
s
=-0.134, 
p=0.294 
r
s
=
-
0.
10
1, 
p=
0.
43
3 
BMI 
r
s
=-
0.074, 
p=0.48
1 
r
s
=0.07
5, 
p=0.47
0 
 
r
s
=0.01
0, 
p=0.92
8 
r
s
=-
0.205, 
p=0.05
7 
r
s
=0.02
9, 
p=0.79
1 
r
s
=0.06
1, 
p=0.57
5 
 
r
s
=-0.218, 
p=0.039 
r
s
=
-
0.
19
1, 
p=
0.
07
1 
 
Highlights 
 Women with eating disorders self-report altered motor inhibition 
 No behavioural differences in reactive inhibition on the stop signal task were observed 
 Proactive inhibition is elevated in adult women with anorexia nervosa 
 Group differences in proactive inhibition are related to intolerance of uncertainty 
 
 
